✦ LIBER ✦

Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine

✍ Scribed by A. D. Miller; G. L. Krauss; F. M. Hamzeh

Book ID: 109337080
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 107 KB
Volume: 109
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.2004.00291.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from Sustained-Release to Imm

Conversion from Sustained-Release to Immediate-Release Bupropion: Patient Tolerability and Economic Impact

✍ Janet L. Mayo; Georgette M. Cahill; Rex S. Lott 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Conversion from immediate-release to ext

Conversion from immediate-release to extended-relase diltiazem in angina pectoris

✍ Peter E. Pool; Udho Thadani; Alan B. Miller; Gregg J. Fromell; Jack Eff 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

1.294 Tolerability with no loss of effic

1.294 Tolerability with no loss of efficacy after overnight conversion from immediate-release ropinirole to an extended-release formulation – ropinirole CR – in restless legs syndrome

✍ S. Isaacson; M. Castiglia; R. Hodge 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Success rate, efficacy, and safety/toler

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease

✍ A. H. V. Schapira; P. Barone; R. A. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Conversion from delayed-release sodium v

Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up

✍ Paul H. McCabe; Nancy C. Michel; Cathy D. McNew; Erik B. Lehman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB